Roberto Miano, MD, Author at Grand Rounds in Urology

Roberto Miano, MD

University of Rome

Rome, Italy

Roberto Miano is an Associate Professor in Urology in the Faculty of Medicine at the University of Rome Tor Vergata. He obtained his MD in 1994 at the University of Rome La Sapienza, followed by clinical specialization in Urology in 2000 at the University of Rome Tor Vergata. Roberto Miano became a consultant in 2003 at the Policlinico Tor Vergata Foundation. He is an active member of several scientific societies, including the European Association of Urology, the American Urological Association, the Italian Society of Urology, the Italian Endourological Association, and the Italian Society of Andrology. He is the Co-Founder and a member of the International Translational Research in Uro-Sciences Team (ITRUST). His main scientific interests are prostate cancer, BPH, and stone disease. Roberto Miano is a member of the Editorial Board of Minerva Urologica & Nefrologica, and has served as a reviewer of several peer-reviewed journals in the same field (European Urology, Urological Research, Medical Science Monitor). He received several awards over the last 10 years for his work on BPH, prostate cancer, and kidney stones. His main clinical interests are the prevention and treatment of urinary stone disease and minimally-invasive treatment for BPH and prostate cancer.

Talks by Roberto Miano, MD

3D Printing and its Infinite Applications

Posted by Roberto Miano, MD | Jun 2018

Robert Miano, MD, discusses 3D printing and its vast potential uses, ranging from the food industry to building new organs. He covers the technology’s history, focusing on different uses for the technology and highlighting its role in urology. He then introduces the iTrust and the FutUrology projects, which will concentrate on innovative urologic technology, such as 3D printing and machine learning.

Transperineal Prostate Biopsy: State of the Art

Posted by Roberto Miano, MD | May 2018

Roberto Miano, MD, compares transperineal versus transrectal access for prostate biopsy. He argues that transperineal is safer in terms of infectious complications and more accurate for detecting cancer versus a transrectal approach. He also discusses proper clinician training, the transperineal approach in MRI-guided fusion biopsy, and emerging software for a local anesthesia free-hand technique.